Pacific Biosciences of California PACB Enterprise value

Enterprise value at other companies

IlluminaILMN

$27.62B+76.4%

Quanterix CorporationQTRX

$192.72M+46.1%

RevvityRVTY

$15.32B+11.3%

Twist Bioscience CorporationTWST

$2.9B+30.4%

Agilent TechnologiesA

$34.39B+5.1%

Rapid Micro BiosystemsRPID

$94.75M-29.9%

FAQ

What is Pacific Biosciences of California's enterprise value?

Pacific Biosciences of California (PACB) reported enterprise value of $521M in Q2 2026.

How has Pacific Biosciences of California's enterprise value changed year-over-year?

Pacific Biosciences of California's enterprise value increased by 46.2% year-over-year, from $356.25M to $521M.

What is the long-term trend for Pacific Biosciences of California's enterprise value?

Over 5 years (2020 to 2025), Pacific Biosciences of California's enterprise value has grown at a -35.5% compound annual growth rate (CAGR), from $5B to $556.35M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.